No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Andon Health Co., Ltd., founded in 1995 and headquartered in Tianjin, China, is a company dedicated to the creation, production, and sales of electronic healthcare devices and intelligent hardware. Their diverse product portfolio includes essential medical monitoring instruments like blood pressure meters, nebulizer systems, blood glucose testing kits, digital thermometers, fetal heart rate monitors, electrocardiogram (ECG) devices, and pulse oximeters. The company also offers smart consumer health technology such as smartwatches and body weight scales.
www.jiuan.comNo one on the platform currently holds 002432.SZ.
No tracked institution reports a position in 002432.SZ as of their last filing.
No one on the platform has traded 002432.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.4% | 36.5% | — | — | — | |
| Rev. Growth % | -47.3% | -7.4% | ||||
| Profit Margin % | 166.0% | 73.6% | 36.7% | |||
| Free Cash Flow Margin % | -31.6% | 25.9% | 3.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.5B | +23.5% | $3.48 | $3.48–$3.48 | — | 1 |
| 2027 | $3.5B | +2.0% | $3.52 | $3.52–$3.52 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002432.SZAndon Health Co., Ltd. | $59.36 | +0.27% | $27.7B | — |
| 002030.SZDaan Gene Co., Ltd. | $5.21 | -2.62% | $7.3B | — |
| 002223.SZJiangsu Yuyue Medical Equipment & Supply Co., Ltd. | $26.07 | +2.24% | $26.1B | — |
| 002422.SZSichuan Kelun Pharmaceutical Co., Ltd. Class A | $40.65 | -1.76% | $64.7B | — |
| 4543.TTerumo Corporation | $2262.00 | +0.87% | $3.34T | — |
| 688289.SSSansure Biotech Inc. | $15.52 | -3.48% |
Source: Financial Modeling Prep · peers by sector/industry
| $9.0B |
| — |
| BDXBecton, Dickinson and Company | $185.92 | +1.65% | $51.2B | — |